Author:
Stock Wendy,Johnson Jeffrey L.,Stone Richard M.,Kolitz Jonathan E.,Powell Bayard L.,Wetzler Meir,Westervelt Peter,Marcucci Guido,DeAngelo Daniel J.,Vardiman James W.,McDonnell Diane,Mrózek Krzysztof,Bloomfield Clara D.,Larson Richard A.
Reference37 articles.
1. Risk-oriented postremission strategies in adult acute lymphoblastic leukemia: prospective confirmation of anthracycline activity in standard-risk class and role of hematopoietic stem cell transplants in high-risk groups;Bassan;Hematol J.,2001
2. Treatment of adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL);Gokbuget;Hematol Oncol Clin North Am.,2000
3. Prospective randomized trial to evaluate 2 delayed granulocyte colony stimulating factor administration schedules after high-dose cytarabine therapy in adult patients with acute lymphoblastic leukemia;Hofmann;Ann Hematol.,2002
4. Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia;Kantarjian;Cancer.,2004
5. The US trials in adult acute lymphoblastic leukemia;Larson;Ann Hematol.,2004
Cited by
104 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献